Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Non-Current Liabilities: 2011-2019

Historic Other Non-Current Liabilities for Niagen Bioscience (NAGE) over the last 6 years, with Dec 2019 value amounting to $169,000.

  • Niagen Bioscience's Other Non-Current Liabilities fell 14.68% to $250,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $250,000, marking a year-over-year decrease of 14.68%. This contributed to the annual value of $169,000 for FY2019, which is 38.55% down from last year.
  • Per Niagen Bioscience's latest filing, its Other Non-Current Liabilities stood at $169,000 for FY2019, which was down 38.55% from $275,000 recorded in FY2018.
  • Niagen Bioscience's 5-year Other Non-Current Liabilities high stood at $389,010 for FY2016, and its period low was $169,000 during FY2019.
  • In the last 3 years, Niagen Bioscience's Other Non-Current Liabilities had a median value of $275,000 in 2018 and averaged $252,667.
  • Per our database at Business Quant, Niagen Bioscience's Other Non-Current Liabilities skyrocketed by 43.02% in 2016 and then slumped by 38.55% in 2019.
  • Yearly analysis of 4 years shows Niagen Bioscience's Other Non-Current Liabilities stood at $272,002 in 2016, then surged by 43.02% to $389,010 in 2016, then decreased by 19.28% to $314,000 in 2017, then decreased by 12.42% to $275,000 in 2018, then crashed by 38.55% to $169,000 in 2019.